Advertise on podcast: BioBoss sponsors by John Simboli

Podcast episodes

Check latest episodes from BioBoss podcast

Stacy Lindborg: CEO of Imunon

2026/01/26

Stacy Lindborg, CEO of Imunon, shares her insights about leadership in biopharma and how Imunon is working to develop medicines that harness the building blocks of life to work in harmony with the body's immune system.

Welcome to Season 8 of BioBoss

2025/12/20

BioBoss podcast host John Simboli reflects on Seasons 1-6 and invites listeners to Season 7 starting in January 2026

Michael Cloonan: CEO of Sionna Therapeutics

2025/11/22

Michael Cloonan, CEO of Sionna Therapeutics, shares his insights about leadership in biopharma and how Sionna is working to restore the cystic fibrosis transmembrane conductance regulator for people living with cystic fibrosis.

Erik van den Berg: CEO of Memo Therapeutics

2025/10/27

Erik van den Berg, CEO of Memo Therapeutics, shares his insights about leadership in biopharma and how Memo is working to develop antibodies to transform the lives of patients with viral infections and cancer.

Bruce Leuchter: CEO of Neurvati Neurosciences

2025/09/29

Bruce Leuchter, CEO of Neurvati Neurosciences, shares his insights about leadership in biopharma and how Neurvati is working to advance drugs with the potential to improve the health and lives of people living with neurological and psychiatric disorders.

Todd Harris: CEO of Tyra Biosciences

2025/08/30

Todd Harris, CEO of Tyra Biosciences, shares his insights about leadership in biopharma and how Tyra is working to develop precision medicines that target large fibroblast growth factor receptor biology.

Eduardo Bravo: CEO of Citryll

2025/07/26

Eduardo Bravo, CEO of Citryll, shares his insights about leadership in biopharma and how Citryll is working to transform the approach to treating immune mediated inflammatory diseases.

Abbas Kazimi: CEO of Nimbus Therapeutics

2025/06/28

Abbas Kazimi, CEO of Nimbus Therapeutics, shares his insights about leadership in biopharma and how Nimbus is working to design and develop small molecule medicines capable of improving patients' lives.

Derek Adams: CEO of Stellular Bio

2025/05/24

Derek Adams, CEO of Stellular Bio, shares his insights about leadership in biopharma and how Stellular Bio is working to expand the reach of regenerative medicine.

Geoffrey Dow: CEO of 60 Degrees Pharmaceuticals

2025/04/29

Geoffrey Dow, CEO of 60 Degrees Pharmaceuticals, shares his insights about leadership in biopharma and how 60 Degrees Pharmaceuticals is working to develop vital medicines to treat and prevent infectious diseases.

Jorge Santos da Silva: Co-Founder and CEO of MoonLake Immunotherapeutics

2025/03/29

Jorge Santos da Silva, co-founder and CEO of MoonLake Immunotherapeutics, shares his insights about leadership in biopharma and how MoonLake Immunotherapeutics is working to develop life changing therapies for people living with serious inflammatory diseases.

Vlad Vitoc - Founder and CEO of MAIA Biotechnology

2025/02/27

Vlad Vitoc, founder and CEO of MAIA Biotechnology, shares his insights with BioBoss host John Simboli about leadership in biopharma and how MAIA is working to develop and deliver innovative medicines to improve and extend the lives of people living with cancer.

What Leads the Leaders? Insights from BioBoss Season 1

2025/01/25

“What leads a leader?” As you listen to clips from BioBoss podcasts, you may hear remarkably consistent ideas about leadership, as shared by BioBoss guests, who reflect on their younger years and how those experiences shaped their desire, and ability to lead.

Welcome to Season 7 of BioBoss

2024/12/05

BioBoss podcast host John Simboli reflects on Seasons 1-6 and invites listeners to Season 7 starting in January 2025

Sam Clark: Founder and CEO of Terran Biosciences

2024/10/31

Sam Clark, founder and CEO of Terran Biosciences, shares his insights with BioBoss host John Simboli about leadership in biopharma and how Terran is working to develop therapeutics and technologies for patients with neurological and psychiatric diseases.